Is Tocilizumab An Effective Therapy For Severe Covid-19: A Single Center Study.

Sarfaraz, Samreen; Shaikh, Quratulain; Iftikhar, Sundus; Herekar, Fivzia Farooq; Saleem, Syed Ghazanfar; Kanani, Fatima

Sarfaraz, Samreen; Shaikh, Quratulain; Iftikhar, Sundus; Herekar, Fivzia Farooq; Saleem, Syed Ghazanfar; Kanani, Fatima.

Afiliación

Sarfaraz S; Infectious Disease Department, The Indus Hospital and Health Network, Karachi.
Shaikh Q; Infectious Disease Department, The Indus Hospital and Health Network, Karachi.
Iftikhar S; Maternal and Child Health, Interactive Research and Development, Karachi.
Herekar FF; Infectious Disease Department, The Indus Hospital and Health Network, Karachi.
Saleem SG; Emergency Department, The Indus Hospital, Karachi.
Kanani F; Chemical Pathology Section, Department of Pathology, The Indus Hospital and Health Network, Karachi, Pakistan.

J Ayub Med Coll Abbottabad ; 34(4): 747-754, 2022.

Article en En | MEDLINE | ID: mdl-36566393

Asunto(s)

Anticuerpos Monoclonales Humanizados; Tratamiento Farmacológico de COVID-19; COVID-19; Interleucina-6; Adulto; Humanos; Interleucina-6/análogos & derivados; Estudios Prospectivos; Estudios Retrospectivos; Anticuerpos Monoclonales Humanizados/uso terapéutico

Palabras clave

COVID-19; Mortality;; Tocilizumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Interleucina-6 / Anticuerpos Monoclonales Humanizados / COVID-19 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: J Ayub Med Coll Abbottabad Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google